Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients

por Palich, R., Veyri, M., Marot, S., Vozy, A., Gligorov, J., Maingon, P., Marcelin, A.-G., Spano, J.-P.
Publicado 2021

Description clinique et diagnostique sérologique des patients présentant des symptômes persistants après suspicion d’infection à SARS-COV-2

por Seang, S., Ktorza, N., Monsel, G., Abdi, B., Marcelin, A., Valantin, M., Pourcher, V., Caumes, E., Katlama, C., Tubiana, R.
Publicado 2020

Long COVID-19 symptoms: Clinical characteristics and recovery rate among non-severe outpatients over a six-month follow-up

por Seang, S., Itani, O., Monsel, G., Abdi, B., Marcelin, A.G., Valantin, M.A., Palich, R., Fayçal, A., Pourcher, V., Katlama, C., Tubiana, R.
Publicado 2022

High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers

por Palich, R., Veyri, M., Vozy, A., Marot, S., Gligorov, J., Benderra, M.-A., Maingon, P., Morand-Joubert, L., Adjoutah, Z., Marcelin, A.-G., Spano, J.-P., Barrière, J.
Publicado 2021